Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions
Homozygous Familial Hypercholesterolemia
Interventions
DRUG

evinacumab

Intravenous (IV) administration

Trial Locations (38)

161

Clinical Trial Site, Roma

1090

Regeneron Study Site, Vienna

2000

Regeneron Study Site, Johannesburg

2050

Clinical Trial Site, Camperdown

3680

Rgeneron Study Site, Kyiv

6000

Clinical Trial Site, Perth

6020

Regeneron Study Site, Innsbruck

7925

Regeneron Study Site, Cape Town

10029

Clinical Trial Site, New York

13385

Clinical Trial Site, Marseille

17674

Regeneron Study Site, Kallithea

19104

Clinical Trial Site, Philadelphia

21079

Clinical Trial Site, Dijon

33434

Clinical Trial Site, Boca Raton

45227

Clinical Trial Site, Cincinnati

45500

Clinical Trial Site, Ioannina

61039

Clinical Trial Site #1, Kharkiv

61176

Clinical Trial Site #2, Kharkiv

75226

Clinical Trial Site, Dallas

75390

Clinical Trial Site, Dallas

75651

Clinical Trial Site, Paris

76075

Clinical Trial Site, Ivano-Frankivsk

80131

Clinical Trial Site, Napoli

90048

Clinical Trial Site, Los Angeles

97239

Clinical Trial Site, Portland

02114

Clinical Trial Site, Boston

G7H 7K9

Clinical Trial Site, Chicoutimi

G1V 4W2

Clinical Trial Site, Québec

121 08

Regeneron Study Site, Prague

474-8710

Clinical Trial Site, Ōbu

830-8522

Regeneron Study Site, Kurume

662-0918

Regeneron Study Site, Nishinomiya

920-8641

Regeneron Study Site, Kanazawa

530-0001

Regeneron Study Site, Kita-ku

564-8565

Regeneron Study Site, Suita

565-0871

Regeneron Study Site, Suita

1105 AZ

Clinical Trial Site, Amsterdam

02660

Clinical Trial Site, Kyiv

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03409744 - Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia | Biotech Hunter | Biotech Hunter